Cme Group Stock Today

CME Stock  USD 218.89  1.39  0.64%   

Performance

6 of 100

 
Low
 
High
Modest

Odds Of Distress

Less than 5

 
100  
 
Zero
Very Low
CME is trading at 218.89 as of the 19th of March 2024, a 0.64 percent increase since the beginning of the trading day. The stock's lowest day price was 217.44. CME has under 5 % chance of experiencing financial distress over the next 2 years but had a somewhat modest performance during the last 90 days. Equity ratings for CME Group are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 18th of February 2024 and ending today, the 19th of March 2024. Click here to learn more.
Business Domain
Financial Services
IPO Date
6th of December 2002
Classification
Financials
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME operates under Financial Data Stock Exchanges classification in the United States and is traded on NASDAQ Exchange. The company has 359.99 M outstanding shares of which 3.32 M shares are currently shorted by investors with about 1.82 days to cover. More on CME Group

Moving together with CME Stock

  0.76ICE Intercontinental Exchange Sell-off TrendPairCorr
  0.8MORN MorningstarPairCorr

Moving against CME Stock

  0.64FG FG Annuities Life Financial Report 1st of May 2024 PairCorr
  0.61DHIL Diamond Hill InvestmentPairCorr
  0.55BY Byline Bancorp Fiscal Quarter End 31st of March 2024 PairCorr
  0.47VALU Value LinePairCorr
  0.45SPGI SP Global Financial Report 25th of April 2024 PairCorr
  0.41AX Axos Financial Financial Report 25th of April 2024 PairCorr

CME Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. CME's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding CME or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, CME's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CME's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
CEOCees Vermaas
Thematic IdeaBlockchain (View all Themes)
Old Names[CENTRAL EURO MEDI-A (CME.SG), Central European Media Enterprises Ltd, AM METALS UCITS ETF, AM METALS UCITS ETF]
Business ConcentrationFinancial Exchanges & Data, Financial Data & Stock Exchanges, Financial Services, SP 500 Index, NASDAQ Composite, NASDAQ Financial 100, NASDAQ Composite Total, Blockchain, Financials, Capital Markets, Financial Data & Stock Exchanges, Financial Services (View all Sectors)
Average Analyst Recommendation
Analysts covering CME report their recommendations after researching CME's financial statements, talking to executives and customers, or listening in on CME's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering CME Group. The CME consensus assessment is calculated by taking the average forecast from all of the analysts covering CME.
Financial Strength
Based on the measurements of operating efficiency obtained from CME's historical financial statements, CME Group may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of CME Group is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.04080.043
Notably Down
Slightly volatile
Gross Profit Margin0.920.8139
Moderately Up
Pretty Stable
Total Current Liabilities98.1 B93.4 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total7.4 B9.6 B
Significantly Down
Slightly volatile
Total Assets136.3 B129.8 B
Sufficiently Up
Slightly volatile
Total Current Assets99.6 B94.9 B
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities3.6 B3.5 B
Sufficiently Up
Slightly volatile
CME's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to CME's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
CME's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of CME's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CME's financial leverage. It provides some insight into what part of CME's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on CME's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how CME deploys its capital and how much of that capital is borrowed.
Liquidity
CME cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 3.88 B in debt with debt to equity (D/E) ratio of 0.12, which may show that the company is not taking advantage of profits from borrowing. CME Group has a current ratio of 1.0, demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due. Debt can assist CME until it has trouble settling it off, either with new capital or with free cash flow. So, CME's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CME Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CME to invest in growth at high rates of return. When we think about CME's use of debt, we should always consider it together with cash and equity.

Free Cash Flow

3.55 Billion
CME Group (CME) is traded on NASDAQ Exchange in USA. It is located in 20 South Wacker Drive, Chicago, IL, United States, 60606 and employs 3,565 people. CME is listed under Financial Exchanges & Data category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 78.8 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CME's market, we take the total number of its shares issued and multiply it by CME's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CME Group runs under Capital Markets sector within Financials industry. The entity has 359.99 M outstanding shares of which 3.32 M shares are currently shorted by investors with about 1.82 days to cover. CME Group has about 2.22 B in cash with 3.45 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.19.
Check CME Probability Of Bankruptcy
Ownership Allocation
CME Group retains a total of 359.99 Million outstanding shares. The majority of CME Group outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CME Group to benefit from reduced commissions. Thereupon, institutional investors are subject to a different set of regulations than regular investors in CME. Please pay attention to any change in the institutional holdings of CME Group as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check CME Ownership Details

CME Stock Price Odds Analysis

What are CME's target price odds to finish over the current price? Based on a normal probability distribution, the odds of CME jumping above the current price in 90 days from now is about 6.57%. The CME Group probability density function shows the probability of CME stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon CME has a beta of 0.2776 suggesting as returns on the market go up, CME average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding CME Group will be expected to be much smaller as well. Additionally, the company has an alpha of 0.038, implying that it can generate a 0.038 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 218.89HorizonTargetOdds Above 218.89
93.32%90 days
 218.89 
6.57%
Based on a normal probability distribution, the odds of CME to move above the current price in 90 days from now is about 6.57 (This CME Group probability density function shows the probability of CME Stock to fall within a particular range of prices over 90 days) .

CME Stock Institutional Holders

Institutional Holdings refers to the ownership stake in CME that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of CME's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing CME's value.
InstituionRecorded OnShares
Norges Bank2023-12-31
4.6 M
Fidelity International Ltd2023-12-31
4.3 M
Fmr Inc2023-09-30
M
Vontobel Asset Management Inc2023-09-30
M
Guardcap Asset Management Limited2023-12-31
M
Fiera Capital Corporation2023-09-30
3.8 M
Neuberger Berman Group Llc2023-09-30
3.8 M
Northern Trust Corp2023-09-30
3.7 M
T. Rowe Price Associates, Inc.2023-12-31
3.6 M
Vanguard Group Inc2023-09-30
33.2 M
Blackrock Inc2023-09-30
23.2 M
View CME Diagnostics

CME Historical Income Statement

CME Group Income Statement is one of the three primary financial statements used for reporting CME's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of CME Group revenue and expense. CME Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, CME's Selling And Marketing Expenses is projected to increase significantly based on the last few years of reporting. The current year's Income Before Tax is expected to grow to about 4.4 B, whereas Total Revenue is forecasted to decline to about 3 B. View More Fundamentals

CME Stock Against Markets

Picking the right benchmark for CME stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in CME stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for CME is critical whether you are bullish or bearish towards CME Group at a given time. Please also check how CME's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in CME without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bollinger Bands Now

   

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Module

CME Corporate Directors

CME corporate directors refer to members of a CME board of directors. The board of directors generally takes responsibility for the CME's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of CME's board members must vote for the resolution. The CME board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Ana DutraIndependent DirectorProfile
Daniel GlickmanIndependent DirectorProfile
Howard SiegelIndependent DirectorProfile
Dennis ChookaszianIndependent DirectorProfile

How to buy CME Stock?

Before investing in CME, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in CME. To buy CME stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of CME. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase CME stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located CME Group stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased CME Group stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as CME Group, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy CME Stock please use our How to Invest in CME guide.

Already Invested in CME Group?

The danger of trading CME Group is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of CME is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than CME. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile CME Group is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for CME Stock analysis

When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.276
Dividend Share
4.4
Earnings Share
8.87
Revenue Per Share
15.512
Quarterly Revenue Growth
0.192
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.